depot medroxyprogesterone Depo-Provera
Selected indexed studies
- Depot Medroxyprogesterone Acetate and Risk of Meningioma in the US. (JAMA Neurol, 2025) [PMID:40892397]
- Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety. (Contraception, 2003) [PMID:12954518]
- Depo provera in perspective. (P N G Med J, 1981) [PMID:6461984]
_Worker-drafted node — pending editorial review._
Connections
depot medroxyprogesterone Depo-Provera is a side effect of
Sources
- Injectable contraception. (1989) pubmed
- Depot Medroxyprogesterone Acetate and Risk of Meningioma in the US. (2025) pubmed
- Depot-medroxyprogesterone acetate injection (Depo-Provera): a highly effective contraceptive option with proven long-term safety. (2003) pubmed
- Depo provera in perspective. (1981) pubmed
- Injectable contraception. (2007) pubmed
- Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents. (1998) pubmed
- Recent clinical issues related to the use of depot medroxyprogesterone acetate (Depo-Provera). (1999) pubmed
- Depot-medroxyprogesterone acetate: an update. (2008) pubmed
- Depot medroxyprogesterone acetate (DMPA, Depo-Provera) in adolescents: what is next after the FDA black box warning. (2005) pubmed
- Use of depo-provera in teens. (1996) pubmed